On Thursday, September 25, 2025, T1International brought policy leaders, advocates, and patients together at NYU Law for “Fixing a Broken System: The Path to Public Pharma in New York,” a major public event highlighting the urgent need for publicly controlled pharmaceutical production to counter skyrocketing drug prices. Read more
At T1International, over a decade of grassroots organizing, storytelling, advocacy, and action have brought us to this critical moment. Our community has grown to include people with diabetes, caregivers, and allies from over 150 countries, all united by a shared vision: a world where everyone has the access to the insulin, supplies, and care they need to survive and truly live. Read more
The recently passed “One Big Beautiful Bill” represents the largest and greatest healthcare loss in American history, cutting health care for 17 million people living in this country. This bill, passed in the United States Congress today, is a profound and deadly cut for people living with diabetes, their families, and marginalized and disabled people across the country.
Read more
As 2024 comes to an end, we’re taking a moment to reflect on the collective power of the T1International community. This year has been filled with challenges and victories as we’ve worked together to fight for affordable and accessible insulin. Here’s a month-by-month look at what we’ve accomplished, thanks to your support and the dedication of advocates across the globe. Read more
On World Diabetes Day, we shine a spotlight on a glaring injustice: millions of people with diabetes in low- and middle-income countries are denied access to affordable insulin pens—a delivery method that could save and transform lives. Pharmaceutical giants Eli Lilly, Novo Nordisk, and Sanofi have monopolized the diabetes market, prioritizing profit over people. It’s time to demand change. It’s time to make it right. Read more